Board of Directors

The Board of Directors sets the goals of the NRS and evaluates and approves plans and program services. Financial oversight is provided by the independent trustees, as well as certified public auditors and state and federal governments.

Richard Gallo, M.D., PhD., Trustee
Dr. Gallo is a renowned physician-scientist and chairman of dermatology at the University of California-San Diego. His groundbreaking research on the role of antimicrobial peptides and elements of innate immunity has translated into a new understanding of the pathophysiology of rosacea — with immediate therapeutic implications. He is one of the highest cited scientific investigators in medicine, with over 45,000 citations of more than 350 publications in prestigious journals.

Zoe Draelos, M.D., Trustee
Dr. Draelos is a leading clinical researcher and consulting professor of dermatology at Duke University, and is a past vice president of the American Academy of Dermatology. She served as the editor in chief of the Journal of Cosmetic Dermatology for 10 years, and has written 14 books, including Cosmetics in Dermatology, Hair Cosmetics and Cosmetic Dermatology: Products and Procedures. Prior to medical school, Dr. Draelos was a Rhodes scholar.

Norman Doucet, Trustee
Mr. Doucet is head of Americas Flexible Workplace at Cushman & Wakefield, and has more than 10 years’ experience in e-commerce management and consulting. He began his career as an infantry officer in the United States Marine Corps, and holds a Master’s degree in English literature.

Keith Flanders, Trustee
Mr. Flanders is director of marketing at LEO Pharma, and has more than 20 years of experience in the pharmaceutical industry. He was previously a senior brand manager with Bayer Healthcare's dermatology division, and holds an MBA from Columbia Business School.

Andrew Huff, President
Mr. Huff has served the NRS since 1996, when he helped launch and maintain the Society’s website as the first online resource for information on rosacea. He has more than 25 years of experience in journalism, communications and medical writing, and is vice president of Glendale Communications Group, which provides professional services for the medical scientific community and health organizations.

Mary Erhard, Secretary
Ms. Erhard is a former editor of Archives of Dermatology and Archives of Ophthalmology, and has written and edited medical articles and research reports on rosacea for more than 15 years. In addition to her work with the American Medical Association, she has been a newspaper reporter in New York and Chicago.

Datha Olney, R.N., Treasurer
Ms. Olney is trained as a registered nurse and has more than 25 years' experience in health care, administration and information technology. She developed and managed the NRS' information services from 1993 to 2006.